Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium effect in patients with atherosclerotic coronary artery disease
IRCT20190724044322N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of selenium in coronary arteriosclerosis, sponsored by Tabriz University of Medical Sciences. Started Jun 2019; status: completed.
02
Drugs
selenium
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20190724044322N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190724044322N1.